679PMeta-analysis of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer. (23rd October 2018) - Nishikawa, K; Koizumi, W; Tsuburaya, A; Yamanaka, T; Morita, S; Fujitani, K; Akamaru, Y; Shimada, K; Hosaka, H; Nakayama, N; Miyashita, Y; Tsujinaka, T; et al.